CY1113902T1 - PROFESSIONAL SYSTEM FOR BIOLOGICAL INGREDIENTS - Google Patents

PROFESSIONAL SYSTEM FOR BIOLOGICAL INGREDIENTS

Info

Publication number
CY1113902T1
CY1113902T1 CY20131100026T CY131100026T CY1113902T1 CY 1113902 T1 CY1113902 T1 CY 1113902T1 CY 20131100026 T CY20131100026 T CY 20131100026T CY 131100026 T CY131100026 T CY 131100026T CY 1113902 T1 CY1113902 T1 CY 1113902T1
Authority
CY
Cyprus
Prior art keywords
professional system
biological ingredients
bacterium
biological
ingredients
Prior art date
Application number
CY20131100026T
Other languages
Greek (el)
Inventor
Tanya Borek
Catherine Federici
Michael P Hite
Christopher London
Stephen J Turner
Original Assignee
Tntgamble, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02766451A external-priority patent/EP1429802B1/en
Application filed by Tntgamble, Inc. filed Critical Tntgamble, Inc.
Publication of CY1113902T1 publication Critical patent/CY1113902T1/en

Links

Abstract

Κοινοποιείται σύνθεση συστήματος παροχής ελεγχόμενης αποδέσμευσης και μέθοδος για τη στοματική χορήγηση ενός βιολογικού συστατικού. Κατά προτίμηση, παρέχεται ένα βακτηρίδιο και κατά μεγαλύτερη προτίμηση το βακτηρίδιο είναι προβιοτικό στη φύση του.A controlled release delivery system composition and method for oral administration of a biological component are disclosed. Preferably, a bacterium is provided and more preferably the bacterium is probiotic in nature.

CY20131100026T 2001-09-28 2013-01-10 PROFESSIONAL SYSTEM FOR BIOLOGICAL INGREDIENTS CY1113902T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32593701A 2001-09-28 2001-09-28
EP02766451A EP1429802B1 (en) 2001-09-28 2002-09-30 Delivery system for biological component

Publications (1)

Publication Number Publication Date
CY1113902T1 true CY1113902T1 (en) 2016-07-27

Family

ID=58448986

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100026T CY1113902T1 (en) 2001-09-28 2013-01-10 PROFESSIONAL SYSTEM FOR BIOLOGICAL INGREDIENTS

Country Status (1)

Country Link
CY (1) CY1113902T1 (en)

Similar Documents

Publication Publication Date Title
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
NO20100302L (en) Compositions containing organic compounds
EE200300237A (en) Diphenyl azetidinone derivatives, their use, drug and method of its preparation
EE200300238A (en) Diphenyl azetidinone derivatives, their use, drug and method of its preparation
CY1105963T1 (en) CAPSOMEPIDIAN VACCINE COMPOSITIONS AND METHODS OF USE
NO331093B1 (en) Somatostatin analogues, method of preparation, pharmaceutical composition and use.
CY1105120T1 (en) THE TREATMENT OF RESPIRATORY DISEASES
NO20012774D0 (en) Preparation and method using essential plant oils
HUP0203056A1 (en) Vaccine composition
BR0314356A (en) Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods using the same
DE60203461D1 (en) Macrolide citrate-containing controlled release formulations
ATE396198T1 (en) 17ALPHA-ALKYL-17BETA-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF, USE OF THE 17ALPHA-ALKYL-17BETA-OXY-ESTRATRIENES FOR THE PRODUCTION OF MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS
NO20042565L (en) Oral pharmaceutical products containing 17 beta-ostradiol-3-lower alkanoate, methods of administration thereof and methods of preparation thereof
ATE302616T1 (en) MEDICINAL COMPOSITIONS FOR ORAL APPLICATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
NO20006138D0 (en) Substituted indolinones, preparation and use thereof as drugs
CY2009017I2 (en) METHOD FOR THE PREPARATION OF 10, 11-DIHYDRO-10-HYDROXY-5H-DIBENZO/B,F/AZEPINO-5-CARBOXAMIDE AND 10,11-DIHYDRO-10-OXO-5H-DIBENZO/B,F/AZEPINO-5- CARBOXAMIDE
DE60209929D1 (en) SUCCINATE OF 5,8,14-TRIAZATETRACYCLOÄ10.3.1.0 2,11 .0 4,9 Ü-HEXADECA-2 (11), 3,5,7,9, -PENTAES AND PHARMACEUTICAL COMPOSITIONS
NO20031622L (en) Medical compositions that rapidly disintegrate in the oral cavity and process for the preparation of the same
DE60301570D1 (en) 1,2,3-SUBSTITUTED INDOLICIDE DERIVATIVES, FGF INHIBITORS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
IL175303A0 (en) Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
DE69716469D1 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN OSTEOGENESE PROMOTING AGENT AND A POLYETHYLENE GLYCOL
CY1107231T1 (en) Substituted 4-Aminocyclohexanol derivatives
DK1165102T3 (en) Matrix protein preparations for grafting in non-mineralized tissue
CY1113902T1 (en) PROFESSIONAL SYSTEM FOR BIOLOGICAL INGREDIENTS
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients